| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.11B | 23.59B | 19.44B | 17.53B | 15.42B | 13.89B |
| Gross Profit | 6.65B | 8.41B | 6.18B | 4.39B | 2.48B | 3.39B |
| EBITDA | 4.73B | 6.25B | 4.37B | 2.79B | 907.40M | 1.92B |
| Net Income | 3.13B | 4.14B | 2.84B | 1.72B | 641.71M | 1.15B |
Balance Sheet | ||||||
| Total Assets | 17.37B | 20.85B | 17.26B | 15.15B | 12.80B | 12.04B |
| Cash, Cash Equivalents and Short-Term Investments | 5.09B | 4.38B | 5.81B | 4.57B | 2.64B | 3.95B |
| Total Debt | 12.03M | 17.04M | 28.44M | 47.61M | 73.58M | 190.68M |
| Total Liabilities | 5.51B | 5.31B | 5.77B | 6.02B | 5.26B | 4.79B |
| Stockholders Equity | 11.86B | 14.88B | 11.49B | 9.12B | 7.54B | 7.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -494.04M | 1.81B | 2.18B | -716.69M | 931.96M |
| Operating Cash Flow | 0.00 | 2.76B | 2.00B | 2.58B | 50.28M | 1.11B |
| Investing Cash Flow | 0.00 | -3.34B | -261.32M | -401.71M | -871.65M | -222.07M |
| Financing Cash Flow | 0.00 | -846.30M | -499.23M | -265.42M | -513.00M | 1.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥73.96B | 18.15 | ― | 0.99% | 21.37% | 44.91% | |
73 Outperform | ¥76.27B | 11.31 | ― | 1.25% | 4.37% | 6.30% | |
69 Neutral | ¥38.59B | 13.51 | ― | 3.05% | 3.03% | ― | |
65 Neutral | ¥15.74B | 15.63 | ― | 1.39% | -1.70% | 409.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥109.37B | 12.80 | ― | 3.81% | -9.72% | -31.50% | |
54 Neutral | ¥10.60B | 31.44 | ― | 3.74% | -15.14% | -73.61% |